Tramadol
Prescription ·Exploratory record · not publication-reviewed ·Updated July 13, 2026
A centrally acting synthetic opioid analgesic with a dual mechanism of action, used for the management of moderate to moderately severe pain. Tramadol has weaker mu-opioid receptor affinity than traditional opioids but supplements its analgesic effect through inhibition of norepinephrine and serotonin reuptake. It carries a lower, but still significant, risk of abuse and respiratory depression.
Exploratory record, not a reviewed medical publication.
See the editorial and medical-review policies for the publication gate.
This generated database record has not completed a claim-level review by a qualified human medical reviewer. Bibliography links and evidence labels are not approval. The page remains available for reference and is excluded from search indexing.
What the research says.
A quick, data-only summary. The full evidence, dosing, and sources are below.
A centrally acting synthetic opioid analgesic with a dual mechanism of action, used for the management of moderate to moderately severe pain. NutriStack rates the supporting evidence as strong. Common adult dosing is Immediate-release: 50–100 mg every 4–6 hours (max 400 mg/day); Extended-release: 100–300 mg once daily (as prescribed by your physician), though a prescriber sets the actual dose. This profile indexes 10 sources.
The bottom line
Evidence rating strong. Most-documented uses: relief of moderate to moderately severe pain, dual mechanism provides multimodal analgesia, lower abuse potential than schedule ii opioids. 10 sources indexed (2020–2025), with 0 interaction records on file.
How it works, mechanistically.
Core mechanism
Binds to mu-opioid receptors in the central nervous system, inhibiting ascending pain pathways. Additionally, tramadol inhibits the reuptake of norepinephrine and serotonin, modulating descending inhibitory pain pathways. The O-desmethyltramadol (M1) metabolite, formed via CYP2D6, has approximately 200-fold greater affinity for mu-opioid receptors than the parent compound.1,2
Dosing & protocol.
Can be taken with or without food; extended-release tablets must be swallowed whole, do not crush, break, or chew
Full safety detail.
Side effects
- Nausea and vomiting
- Dizziness and vertigo
- Constipation
- Headache
- Drowsiness
- Seizures (dose-dependent risk)
- Serotonin syndrome (when combined with serotonergic drugs)
- Respiratory depression
Contraindications
- Known hypersensitivity to tramadol or opioids1,2
- Significant respiratory depression
- Acute or severe bronchial asthma without monitoring
- Known or suspected GI obstruction (paralytic ileus)
- Concurrent use of MAO inhibitors or within 14 days of discontinuation
- Children under 12 years; children under 18 for post-tonsillectomy/adenoidectomy pain4
Sources, by evidence tier.
Numbered references. Citations throughout the page link here.
Meta-analyses & systematic reviews
6- 1Tramadol versus placebo for chronic pain: a systematic review with meta-analysis and trial sequential analysisPMIDBarakji JA, Maagaard M, Petersen JJ et al. · BMJ evidence-based medicine · 2025
Barakji JA, Maagaard M, Petersen JJ et al.. Tramadol versus placebo for chronic pain: a systematic review with meta-analysis and trial sequential analysis. BMJ evidence-based medicine. 2025
- 2Tramadol (with or without acetaminophen) efficacy and harm: Systematic review and meta-analysisPMIDOtte JA, Chu G, Heran B et al. · Canadian family physician Medecin de famille canadien · 2025
Otte JA, Chu G, Heran B et al.. Tramadol (with or without acetaminophen) efficacy and harm: Systematic review and meta-analysis. Canadian family physician Medecin de famille canadien. 2025
- 3The use of tramadol for cancer-associated pain-a systematic reviewPMIDGarlapati S, Alexander R, Kaminski C et al. · Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
Garlapati S, Alexander R, Kaminski C et al.. The use of tramadol for cancer-associated pain-a systematic review. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2025
- 4Efficacy of tramadol for postoperative pain management in dogs: systematic review and meta-analysisPMIDDonati PA, Tarragona L, Franco JVA et al. · Veterinary anaesthesia and analgesia · 2021
Donati PA, Tarragona L, Franco JVA et al.. Efficacy of tramadol for postoperative pain management in dogs: systematic review and meta-analysis. Veterinary anaesthesia and analgesia. 2021
- 5Intraperitoneal Tramadol in Abdominal Surgery: A Systematic ReviewPMIDOtutaha B, MacFater WS, Xia W et al. · The Journal of surgical research · 2020
Otutaha B, MacFater WS, Xia W et al.. Intraperitoneal Tramadol in Abdominal Surgery: A Systematic Review. The Journal of surgical research. 2020
- 6Tramadol for management of fibromyalgia pain and symptoms: Systematic reviewPMIDda Rocha AP, Mizzaci CC, Nunes Pinto ACP et al. · International journal of clinical practice · 2020
da Rocha AP, Mizzaci CC, Nunes Pinto ACP et al.. Tramadol for management of fibromyalgia pain and symptoms: Systematic review. International journal of clinical practice. 2020
Reference material
4- 7Grond S, Sablotzki A. Clinical pharmacology of tramadol. Clin Pharmacokinet. 2004.Source linkedPMID
- 8Dowell D et al. CDC Clinical Practice Guideline for Prescribing Opioids for Pain, United States, 2022. MMWR. 2022.Source linkedPMID
- 9Duehmke RM et al. Tramadol for neuropathic pain in adults. Cochrane Database Syst Rev. 2017.Source linkedPMID
- 10Beakley BD, Kaye AM, Kaye AD. Tramadol, Pharmacology, Side Effects, and Serotonin Syndrome: A Review. Pain physician. 2015Source linkedPMID
Common questions.
Quick answers about Tramadol, drawn from the data on this page.
What is Tramadol?
A centrally acting synthetic opioid analgesic with a dual mechanism of action, used for the management of moderate to moderately severe pain. Tramadol has weaker mu-opioid receptor affinity than traditional opioids but supplements its analgesic effect through inhibition of norepinephrine and serotonin reuptake. It carries a lower, but still significant, risk of abuse and respiratory depression.
What is Tramadol used for?
Commonly cited benefits of Tramadol include: Relief of moderate to moderately severe pain; Dual mechanism provides multimodal analgesia; Lower abuse potential than Schedule II opioids; May be useful for neuropathic pain components. NutriStack rates the overall evidence as strong.
What is a typical dose of Tramadol?
A typical adult dose of Tramadol is Immediate-release: 50–100 mg every 4–6 hours (max 400 mg/day); Extended-release: 100–300 mg once daily (as prescribed by your physician). The commonly recommended form is Immediate-release or extended-release tablet. These are general ranges, not personalized advice; confirm the right dose with a clinician.
What are the side effects of Tramadol?
Reported side effects include nausea and vomiting, dizziness and vertigo, constipation, headache, drowsiness, seizures (dose-dependent risk). This is educational information; check with a healthcare professional before use.
How strong is the evidence for Tramadol?
NutriStack rates this as Strong, meaning multiple high-quality meta-analyses or systematic reviews converge on the same finding. Full tier criteria are at https://nutristackapp.com/methodology/evidence-tiers.
Use this with your stack
Tramadol in NutriStack.
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.